1 results match your criteria: "- Universitätsklinikum Jena -[Affiliation]"
[Pneumococcal vaccine: protection of adults and reduction of antibiotic resistence by vaccination of children with a conjugated vaccine].
Med Monatsschr Pharm
June 2011
Sektion für Klinische Infektiologie, Abteilung für Gastroenterologie, Hepatologie und Infektiologie, Klinik für Innere Medizin II, Universitäatsklinikum Jena, Jena.
Article Synopsis
- Pneumococcal infections, such as pneumonia and meningitis, commonly affect toddlers, the elderly, and those with weakened immune systems, with healthy toddlers acting as primary carriers of the bacteria in their nasopharynx.* -
- There are two types of pneumococcal vaccines: the older polysaccharide vaccine, which offers limited immunity especially in children under two due to their immature immune systems, and a newer conjugate vaccine that effectively stimulates both T and B cell responses.* -
- The introduction of the conjugate vaccine has led to significant reductions in pneumococcal disease rates through "herd protection," benefiting both vaccinated children and the broader population while also helping lower rates of antibiotic resistance.*